Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness
Official title: A Prospective, Single-Center, Single-Arm, Open-Label Clinical Study Evaluating the Long-Term Safety and Efficacy of Transcutaneous Afferent Patterned Stimulation (TAPS) in Patients With Essential Tremor
Run by Ruijin Hospital · NCT07774598 · Data updated 2026-11-12
This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | March 15, 2027 |
| Study ends | June 15, 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT07774598 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 to under 75 with a clinical diagnosis of essential tremor affecting upper limbs, and with impaired function based on TETRAS and BF-ADL scores.
✕Probably not a fit
Patients without meaningful improvement in tremor or daily function, or those experiencing device-related adverse effects, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center, single-arm, open-label study evaluating the long-term safety and effectiveness of transcutaneous afferent patterned stimulation (TAPS) for essential tremor. Eligible adults will receive TAPS over a defined follow-up period, with outcomes tracked over time to assess tremor severity, functional performance, and patient-reported impact on daily life. Safety will be monitored through adverse events and device-related complications. The trial aims to provide clinical evidence on whether long-term TAPS can improve symptoms and quality of life in ET patients. Findings may inform future use of non-invasive neuromodulation as an alternative or adjunct therapy.
Why it matters
Potential benefit: If successful, participants may experience reduced tremor severity and improved daily functioning with a non-invasive treatment option.
How similar studies have gone: Prior work in non-invasive neuromodulation for tremor has shown signals of safety and potential symptom relief, but long-term data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged ≥18 and \<75 years * Clinical diagnosis of essential tremor (ET), characterized by postural and/or kinetic tremor, primarily affecting one or both upper limbs, with or without involvement of other body regions (e.g., head, voice, or lower limbs) * At least one major hand task score ≥2 on the TETRAS (The Essential Tremor Rating Assessment Scale), and a score ≥3 on the Bain \& Findley Activities of Daily Living (BF-ADL) scale * Able and willing to provide written informed consent Exclusion Criteria: * Presence of implanted electronic medical devices (e.g., deep brain stimulator or cardiac pacemaker) * History of thalamotomy or other neurosurgical procedures for tremor * History of epilepsy * Current treatment with botulinum toxin for upper limb tremor * Skin lesions on the upper limb at the stimulation site (e.g., tumors, hemangiomas) * Neurological disorders affecting the upper limbs * Known allergy to device materials (e.g., silicone, cotton textiles) * Pregnant women * Intake of caffeine or excessive alcohol within 8 hours prior to enrollment * Severe cardiovascular or cerebrovascular diseases, or other significant neurological disorders * Inability to comply with study procedures or follow-up
Where it's running
-
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai 200025
Shanghai, China Recruiting
Study contacts
- Study coordinator: Jun Liu, MD,PhD
- Email: jly0520@hotmail.com
- Phone: 021-86-64370045
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Encora X1 in Daily Life for Essential Tremor
This real-world study tests how the Encora X1 wrist device affects day-to-day activities for adults with essential tremor over three years.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Low Intensity Focused Ultrasound for Essential Tremor in Adults
This early-stage, open-label study tests whether repeated low-intensity focused ultrasound can safely and briefly modulate tremor in people with essential tremor.
-
Closed-loop TMS to reduce tremor
This trial tries phase-locked transcranial magnetic stimulation (TMS) to reduce tremor in people with essential tremor or Parkinson's disease.
-
How deep brain stimulation affects learning and producing speech in Parkinson's disease and essential tremor
This research will see if turning deep brain stimulation on and off changes how adults with Parkinson's disease or essential tremor learn and produce new speech sound sequences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.